Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa)

Alina G. Sofronescu, Meredith Ross, Eric Rush, Whitney Goldner

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Objectives: We report a case of discordant total and free testosterone values in a patient with hypogonadism and juvenile hypophosphatasia after he initiated treatment with asfotase alfa, recombinant tissue non-specific alkaline phosphatase. Methods: Total testosterone was evaluated using immunoassay pre and post initiation of therapy with asfotase alfa, and free testosterone was evaluated using radioimmunoassay and LC-MS/MS while on asfotase alfa therapy. Results: Total testosterone measured by immunoassay was normal prior to therapy with asfotase alfa, and was low post initiation of therapy. During the same time frame, free testosterone measured using RAI and total testosterone measured using LC-MS/MS were normal on asfotase alfa therapy. This suggests assay interference with the total testosterone immunoassay. Conclusion: When laboratory results are discordant or do not match the clinical impression, the possibility of assay interference should be considered. Alternative laboratory methods free of the interference should be selected to evaluate these patients. Human genes discussed in the paper: ALPL gene, Approved name: Alkaline phosphatase, liver/bone/kidney, Synonym: Tissue non-specific alkaline phosphatase (TNSAP).

Original languageEnglish (US)
Pages (from-to)118-121
Number of pages4
JournalClinical Biochemistry
Volume58
DOIs
StatePublished - Aug 2018

Keywords

  • Alkaline Phosphatase
  • Juvenile hypophosphatasia
  • Testosterone
  • asfotase alfa

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa)'. Together they form a unique fingerprint.

  • Cite this